Mercer Global Advisors
NNVC icon

Mercer Global Advisors’s NanoViricides NNVC Stock Holding History

Mercer Global Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34K Buy
+1,694
New +$2.32K ﹤0.01% 5554

Other funds holding NNVC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mercer Global Advisors's NNVC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in NanoViricides (NNVC) in Q2 2026: 1,694 shares worth $2.34K. The stake represents ﹤0.01% of the portfolio and ranks #5554 among its holdings.

37 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • Mercer Global Advisors held 1,694 shares of NanoViricides worth $2.34K as of Q2 2026.
  • NanoViricides was a new Mercer Global Advisors position in Q2 2026.
  • NanoViricides made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5554 holding.
  • 37 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.